Kazunori Kawamura Selected Research

Proteins (Proteins, Gene)

1/2024	A first-in-man study of [18F] FEDAC: a novel PET tracer for the 18-kDa translocator protein.
12/2023	Investigating neural dysfunction with abnormal protein deposition in Alzheimer's disease through magnetic resonance spectroscopic imaging, plasma biomarkers, and positron emission tomography.
1/2020	Visualization of AMPA receptors in living human brain with positron emission tomography.
2/2019	Radiosynthesis and in vivo evaluation of 11C-labeled BMS-193885 and its desmethyl analog as PET tracers for neuropeptide Y1 receptors.
1/2016	Efficient radiosynthesis and non-clinical safety tests of the TSPO radioprobe [(18)F]FEDAC: Prerequisites for clinical application.
11/2015	Utility of Translocator Protein (18 kDa) as a Molecular Imaging Biomarker to Monitor the Progression of Liver Fibrosis.
10/2014	Molecular imaging of ectopic metabotropic glutamate 1 receptor in melanoma with a positron emission tomography radioprobe (18) F-FITM.
1/2014	Visualization of acute liver damage induced by cycloheximide in rats using PET with [(18)F]FEDAC, a radiotracer for translocator protein (18 kDa).
7/2013	Synthesis and evaluation of [11C]MMPIP as a potential radioligand for imaging of metabotropic glutamate 7 receptor in the brain.
7/2013	Synthesis, metabolite analysis, and in vivo evaluation of [(11)C]irinotecan as a novel positron emission tomography (PET) probe.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kazunori Kawamura Research Topics

Disease

19	Neoplasms (Cancer) 01/2024 - 02/2004
9	Breast Neoplasms (Breast Cancer) 02/2019 - 04/2009
6	Alzheimer Disease (Alzheimer's Disease) 01/2024 - 05/2011
3	Neuroinflammatory Diseases 01/2024 - 03/2012
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2024 - 11/2022
3	Central Nervous System Diseases (CNS Diseases) 01/2016 - 10/2012
3	Pneumonia (Pneumonitis) 01/2016 - 09/2011
3	Inflammation (Inflammations) 01/2014 - 10/2006
3	Colonic Neoplasms (Colon Cancer) 11/2010 - 08/2006
2	Tauopathies 01/2024 - 01/2020
2	Atrophy 12/2023 - 01/2020
2	Major Depressive Disorder (Major Depressive Disorders) 10/2021 - 04/2014
2	Hypoxia (Hypoxemia) 07/2021 - 09/2019
2	Carcinoma (Carcinomatosis) 02/2021 - 12/2005
2	Glioblastoma (Glioblastoma Multiforme) 09/2019 - 01/2016
2	Non-alcoholic Fatty Liver Disease 01/2016 - 11/2012
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2016 - 11/2015
2	Melanoma (Melanoma, Malignant) 02/2015 - 10/2014
2	Neoplasm Metastasis (Metastasis) 10/2014 - 12/2005
2	Amyloid Plaque 06/2014 - 01/2007
2	Huntington Disease (Huntington's Disease) 04/2014 - 05/2011
2	Human Influenza (Influenza) 05/2011 - 01/2009
2	Ischemia 01/2011 - 06/2010
1	Frontotemporal Dementia (Semantic Dementia) 01/2024
1	Brain Diseases (Brain Disorder) 01/2023
1	Schizophrenia (Dementia Praecox) 01/2023
1	Multiple System Atrophy 10/2022
1	Epilepsy (Aura) 01/2020
1	Temporal Lobe Epilepsy 01/2020
1	Obesity 01/2019
1	Cognitive Dysfunction 06/2018
1	Mental Disorders (Mental Disorder) 06/2018
1	Food Addiction 09/2017
1	Parkinson Disease (Parkinson's Disease) 01/2016
1	Fibrosis (Cirrhosis) 11/2015
1	Carcinogenesis 10/2014
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 04/2014

Drug/Important Bio-Agent (IBA)

23	Proteins (Proteins, Gene)FDA Link 01/2024 - 12/2005
9	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 02/2019 - 04/2009
8	LigandsIBA 10/2021 - 11/2004
6	Biomarkers (Surrogate Marker)IBA 12/2023 - 11/2009
4	Glutamic Acid (Glutamate)FDA Link 01/2023 - 07/2013
3	acetamideIBA 01/2024 - 03/2012
3	tau Proteins (tau Protein)IBA 01/2024 - 12/2022
3	Amyloid (Amyloid Fibrils)IBA 01/2024 - 06/2014
3	ElacridarIBA 02/2019 - 11/2010
3	metabotropic glutamate receptor type 1IBA 01/2016 - 10/2012
2	N- benzyl- N- methyl- 2- (7,8- dihydro- 7- (2- fluoroethyl)- 8- oxo- 2- phenyl- 9H- purin- 9- yl)acetamideIBA 01/2024 - 01/2012
2	Carbon-11IBA 02/2021 - 04/2010
2	Glucose (Dextrose)FDA LinkGeneric 09/2017 - 08/2006
2	LipopolysaccharidesIBA 01/2012 - 09/2011
2	Phosphates (Orthophosphate)IBA 05/2011 - 01/2009
2	Oseltamivir (Tamiflu)FDA Link 05/2011 - 01/2009
2	Ro 64-0802IBA 05/2011 - 01/2009
2	Gefitinib (Iressa)FDA Link 04/2010 - 04/2009
2	GABA-A Receptors (GABA(A) Receptor)IBA 01/2010 - 01/2007
2	EsterasesIBA 01/2009 - 01/2007
2	SA 4503IBA 12/2005 - 11/2004
2	sigma Receptors (sigma Receptor)IBA 12/2005 - 11/2004
2	Haloperidol (Haldol)FDA LinkGeneric 12/2005 - 11/2004
2	Tyrosine (L-Tyrosine)FDA Link 04/2005 - 02/2004
1	RetinoidsIBA 01/2023
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2023
1	Antipsychotic Agents (Antipsychotics)IBA 01/2023
1	SynucleinsIBA 10/2022
1	pyridineIBA 07/2021
1	fluoromisonidazoleIBA 07/2021
1	DNA (Deoxyribonucleic Acid)IBA 02/2021
1	3- (6- methylpyridin- 2- ylethynyl)cyclohex- 2- enone- O- methyloximeIBA 01/2020
1	Flumazenil (Romazicon)FDA LinkGeneric 01/2020
1	AMPA Receptors (AMPA Receptor)IBA 01/2020
1	2- (4,5- dihydro- 1H- imidazol- 2- yl)- 1- methyl- 1H- indoleIBA 01/2019
1	Histamine H3 Receptors (Histamine H3 Receptor)IBA 06/2018
1	Ghrelin ReceptorsIBA 09/2017
1	alpha-SynucleinIBA 01/2016
1	cyclic arginine-glycine-aspartic acid peptideIBA 01/2016
1	Radioisotopes (Radionuclides)IBA 01/2016
1	Peptides (Polypeptides)IBA 01/2016
1	SolutionsIBA 01/2016
1	IntegrinsIBA 01/2016
1	arginyl-glycyl-aspartic acidIBA 01/2016
1	Carbon Tetrachloride (Tetrachloromethane)IBA 11/2015
1	Oncogene Proteins (Oncogene Protein)IBA 10/2014
1	N-methylbenzamideIBA 10/2014
1	agerafenibIBA 08/2014
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 08/2014
1	Phosphotransferases (Kinase)IBA 08/2014
1	AminesIBA 06/2014
1	Nortriptyline (Aventyl)FDA LinkGeneric 04/2014
1	Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA 04/2014
1	PK 11195 (PK11195)IBA 11/2012
1	nasIBA 11/2012
1	Choline (Choline Chloride)IBA 11/2012
1	Methionine (L-Methionine)FDA Link 11/2012
1	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 10/2012
1	Messenger RNA (mRNA)IBA 03/2012

Therapy/Procedure

3	Therapeutics 11/2022 - 04/2009
2	Drug Therapy (Chemotherapy) 06/2010 - 01/2007
1	Radiotherapy 09/2019
1	Precision Medicine 01/2016